Form 4 for VHC VirnetX Holding Corp
Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-12 · accession 0001415889-24-026849 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-14 | 2024-11-12 | VHC | Short Robert D III | Chief Scientist | A - Grant | $0.00 | +30.0K | 31.9K | +1,574% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-12 | A | A | 30,000 | $0.00 | 31,906 | D | — | — | (F1) 1/4 of the total number of restricted shares ("Restricted Stock") shall vest and become exercisable on the one-year anniversary of the grant date, and 1/4 of the total number of Restricted Stock shall vest and become exercisable on each yearly anniversary thereafter, so long as the individual's continuous status as a Service Provider (as defined in the Company's Amended and Restated 2013 Equity Incentive Plan) has not terminated prior to each such date. If a Change in Control occurs, all of the Restricted Stock then unvested as of the date of the Change in Control, will vest and become exercisable immediately prior to the consummation of the Change in Control transaction. (F3) Reflects the issuance of vested Restricted Stock Units directly to The Short Revocable Living Trust. (F2) The number of shares beneficially owned reflects the Issuer's 1-for-20 reverse stock split effected October 25, 2023. |